Table 1 Patient characteristics
From: Distance saturation product predicts health–related quality of life among sarcoidosis patients
Age (Mean ± SD) | 45.9 ± 11.1 | Disease, N (%) | |
|---|---|---|---|
BMI (Mean ± SD) | 32 ± 8.2 | Inactive | 45 (28) |
Gender, N (%) | Active/Symptomatic† | 117 (72) | |
Male | 45 (28) | Organ Involvements N (%) | |
Female | 117 (72) | Lung | 152 (94) |
Race, N (%) | Skin | 49 (30) | |
African American | 139 (86.8) | Eye | 43 (26) |
White | 21(13.2) | Heart | 11 (6) |
CXR stage, N (%) | Liver | 18 (11) | |
0 | 13 (8.2) | CNS | 13 (6) |
1 | 28 (17.7) | PH* | 28 (17) |
2 | 65 (41.5) | Medication, N (%) | |
3 | 24 (14) | Steroidal | 94 (58) |
4 | 29(18.2) | IMD‡ | 68 (42) |
Non-smokers | 123 (76) | Steroidal + IMD | 77 (47) |